Skip to content
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc.

SNOA

Sonoma Pharmaceuticals is a global healthcare company specializing in the development and production of stabilized hypochlorous acid (HOCl) solutions for a variety of medical and consumer applications.

Market cap
$6.03M-6.8%

Table of contents

Earnings

Next report

Aug 6, 2026 (In 3 weeks)
Revenue estimate$5.0M
EPS estimate-$0.30

Competitors

Profile

Sonoma Pharmaceuticals is a global healthcare company specializing in the development and production of stabilized hypochlorous acid (HOCl) solutions for a variety of medical and consumer applications. The company's core value proposition lies in its proprietary HOCl technology, which is clinically proven to manage skin conditions, wounds, and infections safely without damaging healthy tissue. Sonoma operates a vertically integrated model, manufacturing its products in Mexico and distributing them across more than 55 countries through both direct sales and strategic partnerships.

Competitive position

Sonoma is a pioneer in stabilized HOCl technology with over 20 years of manufacturing expertise and 22 FDA clearances. It differentiates itself through product stability and safety profiles compared to traditional steroids and antibiotics.

GeographiesUnited States, Mexico, Europe, United Kingdom, Middle East, Asia
Customer segmentsHealthcare Professionals, Retail Consumers, Veterinarians, Hospital Systems
Business modelManufacturing, Direct-to-Consumer (DTC), B2B Distribution, Licensing and Private Label
SuppliersRaw material suppliers, Proprietary manufacturing equipment, Regulatory bodies (FDA, EMA, Ministry of Health Mexico)
CustomersNational retail chains, Hospital procurement systems, Dermatology clinics, Pet specialty retailers, Online direct-to-consumer platforms
Listed2007
Employees171.0
CEOAmy Trombly
FilingsSEC EDGAR

Questions, answered.

What is Sonoma Pharmaceuticals, Inc.'s market cap?
Sonoma Pharmaceuticals, Inc. (SNOA) has a market capitalization of $6.0M and trades on NASDAQ.
Who are Sonoma Pharmaceuticals, Inc.'s competitors?
Sonoma Pharmaceuticals, Inc.'s key competitors include Zoetis Inc., Bausch Health Companies Inc., NexGel, Inc Common Stock, and others. These companies compete in similar markets and product categories.
Who does Sonoma Pharmaceuticals, Inc. partner with?
Sonoma Pharmaceuticals, Inc.'s notable partners include CVS, Walmart, Medline Industries, LP, and others.
What subsidiaries does Sonoma Pharmaceuticals, Inc. have?
Sonoma Pharmaceuticals, Inc.'s subsidiaries include Oculus Technologies of Mexico, S.A. de C.V., Sonoma Pharmaceuticals Netherlands, B.V..
Where is Sonoma Pharmaceuticals, Inc. headquartered?
Sonoma Pharmaceuticals, Inc. is headquartered in United States of America and employs approximately 171 people. It has been publicly traded since 2007.